Prague Med. Rep. 2018, 119, 85-96

https://doi.org/10.14712/23362936.2018.8

Olfaction and Colour Vision: What Can They Tell Us about Parkinson’s Disease?

Irene Dall’Antonia, Karel Šonka, Petr Dušek

Department of Neurology and Centre of Clinical Neuroscience, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic

Received April 24, 2018
Accepted October 5, 2018

References

1. American Academy of Sleep Medicine (2014) International Classification of Sleep Disorders.
2. Armstrong, R. A. (2015) Oculo-visual dysfunction in Parkinson’s disease. J. Parkinsons Dis. 5, 715–726. <https://doi.org/10.3233/JPD-150686> <PubMed>
3. Baba, T., Kikuchi, A., Hirayama, K., Nishio, Y., Hosokai, Y., Kanno, S., Hasegawa, T., Sugeno, N., Konno, M., Suzuki, K., Takahashi, S., Fukuda, H., Aoki, M., Itoyama, Y., Mori, E., Takeda, A. (2012) Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson’s disease: a 3 year longitudinal study. Brain 135, 161–169. <https://doi.org/10.1093/brain/awr321>
4. Berg, D., Postuma, R. B., Adler, C. H., Bloem, B. R., Chan, P., Dubois, B., Gasser, T., Goetz, C. G., Halliday, G., Joseph, L., Lang, A. E., Liepelt-Scarfone, I., Litvan, I., Marek, K., Obeso, J., Oertel, W., Olanow, C. W., Poewe, W., Stern, M., Deuschl, G. (2015) MDS research criteria for prodromal Parkinson’s disease. Mov. Disord. 30, 1600–1611. <https://doi.org/10.1002/mds.26431>
5. Bernis, M. E., Babila, J. T., Breid, S., Wusten, K. A., Wullner, U., Tamguney, G. (2015) Prion-like propagation of human brain-derived alpha-synuclein in transgenic mice expressing human wild-type alpha-synuclein. Acta Neuropathol. Commun. 3, 75. <https://doi.org/10.1186/s40478-015-0254-7> <PubMed>
6. Bertrand, J. A., Bedetti, C., Postuma, R. B., Monchi, O., Genier Marchand, D., Jubault, T., Gagnon, J. F. (2012) Color discrimination deficits in Parkinson’s disease are related to cognitive impairment and white-matter alterations. Mov. Disord. 27, 1781–1788. <https://doi.org/10.1002/mds.25272>
7. Braak, H., Del Tredici, K., Rub, U., De Vos, R. A., Jansen Steur, E. N., Braak, E. (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol. Aging 24, 197–211. <https://doi.org/10.1016/S0197-4580(02)00065-9>
8. Brooks, D. J., Seppi, K.; Neuroimaging Working Group on M. S. A. (2009) Proposed neuroimaging criteria for the diagnosis of multiple system atrophy. Mov. Disord. 24, 949–964. <https://doi.org/10.1002/mds.22413>
9. Dain, S. J. (2004) Clinical colour vision tests. Clin. Exp. Optom. 87, 276–293. <https://doi.org/10.1111/j.1444-0938.2004.tb05057.x>
10. Diederich, N. J., Raman, R., Leurgans, S., Goetz, C. G. (2002) Progressive worsening of spatial and chromatic processing deficits in Parkinson disease. Arch. Neurol. 59, 1249–1252. <https://doi.org/10.1001/archneur.59.8.1249>
11. Domellof, M. E., Lundin, K. F., Edstrom, M., Forsgren, L. (2017) Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson’s disease. Parkinsonism Relat. Disord. 38, 41–47. <https://doi.org/10.1016/j.parkreldis.2017.02.017>
12. Doty, R. L. (2005) Clinical studies of olfaction. Chem. Senses 30, i207–i209 (Suppl. 1). <https://doi.org/10.1093/chemse/bjh187>
13. Doty, R. L. (2012) Olfaction in Parkinson’s disease and related disorders. Neurobiol. Dis. 46, 527–552. <https://doi.org/10.1016/j.nbd.2011.10.026> <PubMed>
14. Doty, R. L., Shaman, P., Kimmelman, C. P., Dann, M. S. (1984) University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic. Laryngoscope 94, 176–178. <https://doi.org/10.1288/00005537-198402000-00004>
15. Ferini-Strambi, L., Marelli, S., Galbiati, A., Rinaldi, F., Giora, E. (2014a) REM Sleep Behavior Disorder (RBD) as a marker of neurodegenerative disorders. Arch. Ital. Biol. 152, 129–146.
16. Ferini-Strambi, L., Oertel, W., Dauvilliers, Y., Postuma, R. B., Marelli, S., Iranzo, A., Arnulf, I., Hogl, B., Manni, R., Miyamoto, T., Fantini, M. L., Puligheddu, M., Jennum, P., Sonka, K., Santamaria, J., Zucconi, M., Rancoita, P. M., Leu-Semenescu, S., Frauscher, B., Terzaghi, M., Miyamoto, M., Unger, M., Stiasny-Kolster, K., Desautels, A., Wolfson, C., Pelletier, A., Montplaisir, J. (2014b) Autonomic symptoms in idiopathic REM behavior disorder: a multicentre case-control study. J. Neurol. 261, 1112–1118. <https://doi.org/10.1007/s00415-014-7317-8>
17. Gilman, S., Wenning, G. K., Low, P. A., Brooks, D. J., Mathias, C. J., Trojanowski, J. Q., Wood, N. W., Colosimo, C., Durr, A., Fowler, C. J., Kaufmann, H., Klockgether, T., Lees, A., Poewe, W., Quinn, N., Revesz, T., Robertson, D., Sandroni, P., Seppi, K., Vidailhet, M. (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71, 670–676. <https://doi.org/10.1212/01.wnl.0000324625.00404.15> <PubMed>
18. Goedert, M., Spillantini, M. G., Del Tredici, K., Braak, H. (2013) 100 years of Lewy pathology. Nat. Rev. Neurol. 9, 13–24. <https://doi.org/10.1038/nrneurol.2012.242>
19. Halliday, G. M., Holton, J. L., Revesz, T., Dickson, D. W. (2011) Neuropathology underlying clinical variability in patients with synucleinopathies. Acta Neuropathol. 122, 187–204. <https://doi.org/10.1007/s00401-011-0852-9>
20. Iranzo, A., Valldeoriola, F., Lomena, F., Molinuevo, J. L., Serradell, M., Salamero, M., Cot, A., Ros, D., Pavia, J., Santamaria, J., Tolosa, E. (2011) Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol. 10, 797–805. <https://doi.org/10.1016/S1474-4422(11)70152-1>
21. Iranzo, A., Serradell, M., Vilaseca, I., Valldeoriola, F., Salamero, M., Molina, C., Santamaria, J., Tolosa, E. (2013) Longitudinal assessment of olfactory function in idiopathic REM sleep behavior disorder. Parkinsonism Relat. Disord. 19, 600–604. <https://doi.org/10.1016/j.parkreldis.2013.02.009>
22. Iranzo, A., Fernandez-Arcos, A., Tolosa, E., Serradell, M., Molinuevo, J. L., Valldeoriola, F., Gelpi, E., Vilaseca, I., Sanchez-Valle, R., Llado, A., Gaig, C., Santamaria, J. (2014) Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients. PLoS One 9, e89741. <https://doi.org/10.1371/journal.pone.0089741> <PubMed>
23. Kopal, A., Mejzlikova, E., Preiningerova, J. L., Brebera, D., Ulmanova, O., Ehler, E., Roth, J. (2015) Changes of retina are not involved in the genesis of visual hallucinations in Parkinson’s disease. Parkinsons Dis. 2015, 709191.
24. Lawton, M., Hu, M. T., Baig, F., Ruffmann, C., Barron, E., Swallow, D. M., Malek, N., Grosset, K. A., Bajaj, N., Barker, R. A., Williams, N., Burn, D. J., Foltynie, T., Morris, H. R., Wood, N. W., May, M. T., Grosset, D. G., Ben-Shlomo, Y. (2016) Equating scores of the University of Pennsylvania Smell Identification Test and Sniffin’ Sticks test in patients with Parkinson’s disease. Parkinsonism Relat. Disord. 33, 96–101. <https://doi.org/10.1016/j.parkreldis.2016.09.023> <PubMed>
25. Lee, D. H., Oh, J. S., Ham, J. H., Lee, J. J., Lee, I., Lee, P. H., Kim, J. S., Sohn, Y. H. (2015) Is normosmic Parkinson disease a unique clinical phenotype? Neurology 85, 1270–1275. <https://doi.org/10.1212/WNL.0000000000001999>
26. Li, Y., Kang, W., Yang, Q., Zhang, L., Zhang, L., Dong, F., Chen, S., Liu, J. (2017) Predictive markers for early conversion of iRBD to neurodegenerative synucleinopathy diseases. Neurology 88, 1493–1500. <https://doi.org/10.1212/WNL.0000000000003838> <PubMed>
27. Mahlknecht, P., Seppi, K., Poewe, W. (2015) The concept of prodromal Parkinson’s disease. J. Parkinsons Dis. 5, 681–697. <https://doi.org/10.3233/JPD-150685> <PubMed>
28. Manni, R., Ratti, P. L., Terzaghi, M. (2011) Secondary “incidental” REM sleep behavior disorder: do we ever think of it? Sleep Med. 12, S50–S53 (Suppl. 2). <https://doi.org/10.1016/j.sleep.2011.10.011>
29. Marques, O., Outeiro, T. F. (2012) Alpha-synuclein: from secretion to dysfunction and death. Cell Death Dis. 3, e350. <https://doi.org/10.1038/cddis.2012.94> <PubMed>
30. McKeith, I. G., Boeve, B. F., Dickson, D. W., Halliday, G., Taylor, J. P., Weintraub, D., Aarsland, D., Galvin, J., Attems, J., Ballard, C. G., Bayston, A., Beach, T. G., Blanc, F., Bohnen, N., Bonanni, L., Bras, J., Brundin, P., Burn, D., Chen-Plotkin, A., Duda, J. E., El-Agnaf, O., Feldman, H., Ferman, T. J., Ffytche, D., Fujishiro, H., Galasko, D., Goldman, J. G., Gomperts, S. N., Graff-Radford, N. R., Honig, L. S., Iranzo, A., Kantarci, K., Kaufer, D., Kukull, W., Lee, V. M. Y., Leverenz, J. B., Lewis, S., Lippa, C., Lunde, A., Masellis, M., Masliah, E., Mclean, P., Mollenhauer, B., Montine, T. J., Moreno, E., Mori, E., Murray, M., O’Brien, J. T., Orimo, S., Postuma, R. B., Ramaswamy, S., Ross, O. A., Salmon, D. P., Singleton, A., Taylor, A., Thomas, A., Tiraboschi, P., Toledo, J. B., Trojanowski, J. Q., Tsuang, D., Walker, Z., Yamada, M., Kosaka, K. (2017) Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium. Neurology 89, 88–100. <https://doi.org/10.1212/WNL.0000000000004058> <PubMed>
31. Muller, T., Kuhn, W., Buttner, T., Eising, E., Coenen, H., Haas, M., Przuntek, H. (1998) Colour vision abnormalities do not correlate with dopaminergic nigrostriatal degeneration in Parkinson’s disease. J. Neurol. 245, 659–664.
32. Normando, E. M., Davis, B. M., De Groef, L., Nizari, S., Turner, L. A., Ravindran, N., Pahlitzsch, M., Brenton, J., Malaguarnera, G., Guo, L., Somavarapu, S., Cordeiro, M. F. (2016) The retina as an early biomarker of neurodegeneration in a rotenone-induced model of Parkinson’s disease: Evidence for a neuroprotective effect of rosiglitazone in the eye and brain. Acta Neuropathol. Commun. 4, 86. <https://doi.org/10.1186/s40478-016-0346-z> <PubMed>
33. Peřinová, P., Plchová, P., Bušková, J., Kemlink, D., Ibarburu Lorenzo Y. Losada, V., Dostálová, S., Vorlová, T., Šonka, K. (2018) Patients with idiopathic REM sleep behavior disorder follow-up – Phenoconversion into parkinsonian syndrome and dementia. Cesk. Slov. Neurol. N 2, 205–207. <https://doi.org/10.14735/amcsnn2018205>
34. Postuma, R. B., Montplaisir, J. Y. (2014) Antidepressants and REM behavior disorder. Sleep 37, 1395. <https://doi.org/10.5665/sleep.3940> <PubMed>
35. Postuma, R. B., Berg, D. (2016) Advances in markers of prodromal Parkinson disease. Nat. Rev. Neurol. 12, 622–634. <https://doi.org/10.1038/nrneurol.2016.152>
36. Postuma, R. B., Gagnon, J. F., Vendette, M., Desjardins, C., Montplaisir, J. Y. (2011) Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann. Neurol. 69, 811–818. <https://doi.org/10.1002/ana.22282>
37. Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., Halliday, G., Goetz, C. G., Gasser, T., Dubois, B., Chan, P., Bloem, B. R., Adler, C. H., Deuschl, G. (2015a) MDS clinical diagnostic criteria for Parkinson’s disease. Mov. Disord. 30, 1591–1601. <https://doi.org/10.1002/mds.26424>
38. Postuma, R. B., Gagnon, J. F., Bertrand, J. A., Genier Marchand, D., Montplaisir, J. Y. (2015b) Parkinson risk in idiopathic REM sleep behavior disorder: preparing for neuroprotective trials. Neurology 84, 1104–1113. <https://doi.org/10.1212/WNL.0000000000001364> <PubMed>
39. Purves, D. (2004) Neuroscience. Sinauer Associates, Sunderland.
40. Rusz, J., Hlavnicka, J., Tykalova, T., Buskova, J., Ulmanova, O., Ruzicka, E., Sonka, K. (2016) Quantitative assessment of motor speech abnormalities in idiopathic rapid eye movement sleep behaviour disorder. Sleep Med. 19, 141–147. <https://doi.org/10.1016/j.sleep.2015.07.030>
41. Schenck, C. H., Bundlie, S. R., Ettinger, M. G., Mahowald, M. W. (1986) Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 9, 293–308. <https://doi.org/10.1093/sleep/9.2.293>
42. Schenck, C. H., Boeve, B. F., Mahowald, M. W. (2013) Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med. 14, 744–748. <https://doi.org/10.1016/j.sleep.2012.10.009>
43. Simunovic, M. P. (2016) Acquired color vision deficiency. Surv. Ophthalmol. 61, 132–155. <https://doi.org/10.1016/j.survophthal.2015.11.004>
44. Spillantini, M. G., Goedert, M. (2000) The alpha-synucleinopathies: Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy. Ann. N. Y. Acad. Sci. 920, 16–27. <https://doi.org/10.1111/j.1749-6632.2000.tb06900.x>
45. Uchihara, T., Giasson, B. I. (2016) Propagation of alpha-synuclein pathology: Hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies. Acta Neuropathol. 131, 49–73. <https://doi.org/10.1007/s00401-015-1485-1> <PubMed>
46. Vesela, O., Ruzicka, E., Jech, R., Roth, J., Stepankova, K., Mecir, P., Solano, Z., Preclikova, E. (2001) Colour discrimination impairment is not a reliable early marker of Parkinson’s disease. J. Neurol. 248, 975–978.
47. Willis, G. L., Freelance, C. B. (2017) Neurochemical systems of the retina involved in the control of movement. Front. Neurol. 8, 324. <https://doi.org/10.3389/fneur.2017.00324> <PubMed>
front cover

ISSN 1214-6994 (Print) ISSN 2336-2936 (Online)

Archive